| 000 | 03233cam a22004094a 4500 | ||
|---|---|---|---|
| 999 |
_c7376 _d7376 |
||
| 001 | 14964502 | ||
| 005 | 20190509110122.0 | ||
| 008 | 070809s2008 nyua b 001 0 eng | ||
| 010 | _a 2007033181 | ||
| 020 | _a9780824758097 (hb : alk. paper) | ||
| 020 | _a0824758099 (hb : alk. paper) | ||
| 040 |
_aDNLM/DLC _cDLC _dDLC _erda |
||
| 050 | 0 | 0 |
_aRS201.S57 _bP74 2008 |
| 082 | 0 | 0 |
_a615.19 _222 _bP |
| 245 | 0 | 0 |
_aPreformulation solid dosage form development / _cedited by Moji C. Adeyeye, Harry G. Brittain. |
| 260 |
_aNew York : _bInforma Healthcare USA, _cc2008. |
||
| 300 |
_aviii, 596 p. : _bill. ; _c24 cm. |
||
| 336 |
_2rdacontent _atext |
||
| 337 |
_2rdamedia _aunmediated |
||
| 338 |
_2rdacarrier _avolume |
||
| 440 | 0 |
_aDrugs and the pharmaceutical sciences ; _v178 |
|
| 504 | _aIncludes bibliographical references and index. | ||
| 505 | 0 | _aAccelerating the course of preliminary-preformulation through prediction of molecular physical properties and integrated analytical data management / Robert S. DeWitte, Michel Hachey, and Harry G. Brittain -- Prediction of crystallographic characteristics / Steve Spanton -- Salt selection for pharmaceutical compounds / Sherif I. Badawy, Miriam K. Franchini, and Munir A. Hussain -- Intelligent preformulation design and predictions using artificial neural networks / Nkere K. Ebube -- Developing a profile of the active pharmaceutical ingredient / Harry G. Brittain -- Particle morphology and characterization in preformulation / Alan Rawle -- Preparation and identification of polymorphs and solvatomorphs / Harry G. Brittain -- X-ray diffraction methods for the characterization of solid pharmaceutical materials / Jean Blachere and Harry G. Brittain -- Spectroscopic methods for the characterization of drug substances / Harry G. Brittain -- Thermal analysis and calorimetric methods for the characterization of new crystal forms / Dennette Murphy Shelley Rabel -- Solubility methods for the characterization of new crystal forms / Harry G. Brittain -- Overview of the solid dosage form preformulation program / Harry G. Brittain -- Drug-excipient interactions appropriate to solid dosage forms / Moji Christianah Adeyeye -- Methods for the determination of the physical and chemical stability of a new solid dosage form / Harry G. Brittain -- Dissolution testing / Chuck Collins and George Wong -- Structure, content, and format of the preformulation report / Ram N. Gidwani -- Significance of drug substance physicochemical properties in regulatory quality by design / Sau Lawrence Lee, Andre S. Raw, and Lawrence Yu. | |
| 650 | 0 |
_aSolid dosage forms. _928023 |
|
| 650 | 0 | _aDrug development. | |
| 650 | 0 | _aPharmaceutical chemistry. | |
| 650 | 1 | 2 | _aChemistry, Pharmaceutical. |
| 650 | 2 | 2 | _aDosage Forms. |
| 650 | 2 | 2 |
_aPharmaceutical Preparations _xchemical synthesis. |
| 700 | 1 | _aAdeyeye, Moji C. | |
| 700 | 1 | _aBrittain, H. G. | |
| 856 | 4 | 1 |
_3Table of contents only _uhttp://www.loc.gov/catdir/toc/ecip0725/2007033181.html |
| 856 | 4 | 2 |
_3Publisher description _uhttp://www.loc.gov/catdir/enhancements/fy0740/2007033181-d.html |
| 856 | 4 | 2 |
_3Abstract _uhttp://repository.fue.edu.eg/xmlui/handle/123456789/1671 |
| 942 |
_cBK _2ddc |
||